Rubaiya Anika | Health | Innovative Research Award

Published on by Research Hypothesis

Innovative Research Award

Rubaiya Anika
Mount Sinai Hospital, United States

Rubaiya Anika
Affiliation Mount Sinai Hospital
Country United States
Documents 1
Subject Area Health
Event International Research Hypothesis Excellence Award
ORCID 0009-0005-9072-732X

Rubaiya Anika is a researcher affiliated with Mount Sinai Hospital in the United States whose documented research contribution addresses environmental exposure and biological aging. Her listed journal article examines urinary organophosphate metabolites in relation to laboratory-derived phenotypic aging acceleration among U.S. adults using data from the National Health and Nutrition Examination Survey (NHANES) covering 1999–2018. The work was published in the International Journal of Environmental Research and Public Health in August 2026 and provides a research contribution at the intersection of environmental health, exposure science, epidemiology, and aging research. [1]

Abstract

The research contribution associated with Rubaiya Anika investigates the relationship between urinary organophosphate metabolites and laboratory-derived phenotypic aging acceleration in U.S. adults. The study, titled Urinary Organophosphate Metabolites and Laboratory-Derived Phenotypic Aging Acceleration in U.S. Adults: Evidence from NHANES 1999–2018, uses population-based NHANES data to examine an environmental exposure question within an aging-related epidemiological framework. The article was published in the International Journal of Environmental Research and Public Health in August 2026 and is identified by DOI 10.3390/ijerph23091126. [1]

Keywords

  • Innovative Research Award
  • Rubaiya Anika
  • Organophosphate metabolites
  • Phenotypic aging
  • Environmental health

Introduction

Environmental exposures are an important area of public-health research because chemical exposures may vary across populations and may be investigated in relation to measurable biological and health outcomes. Organophosphate metabolites measured in urine can serve as biomarkers of exposure to organophosphate compounds, while phenotypic measures of aging can provide quantitative indicators for studying biological aging in epidemiological populations. The reported study brings these concepts together by analyzing nationally collected U.S. health data across multiple NHANES cycles from 1999 through 2018. [1]

Research Profile

Rubaiya Anika is identified in the supplied publication record as an author affiliated with Mount Sinai Hospital, United States. The documented subject area is Health, with the research contribution positioned within environmental and population health. The available publication record contains one indexed document supplied for this recognition profile.[1]

Research Contributions

The principal documented contribution is the study of urinary organophosphate metabolites in relation to laboratory-derived phenotypic aging acceleration. This research connects environmental exposure assessment with an aging-related outcome and uses nationally collected health-survey data as its analytical foundation. [1]

  • Evaluation of urinary organophosphate metabolite measurements as indicators of environmental exposure.
  • Investigation of phenotypic aging acceleration as a measurable aging-related outcome.
  • Use of NHANES data spanning 1999–2018 to support population-based analysis.
  • Integration of environmental epidemiology and biological aging research.[1]

Publications

The available record identifies one journal article associated with Rubaiya Anika:

Urinary Organophosphate Metabolites and Laboratory-Derived Phenotypic Aging Acceleration in U.S. Adults: Evidence from NHANES 1999–2018

The publication lists Rubaiya Anika, Matthew Untalan, Emanuela Taioli, and Stephanie Tuminello as contributors. The DOI provides a persistent identifier for the journal article and supports direct access to its bibliographic record. [1]

Research Impact

The documented research has potential relevance to environmental and population health because it investigates whether measurable environmental exposure biomarkers are associated with an aging-related phenotype in adults. Research of this type can contribute to hypothesis generation, exposure surveillance, and the identification of questions that may warrant further investigation through longitudinal, mechanistic, or experimental studies. [1]

Award Suitability

The documented publication provides a substantive basis for considering Rubaiya Anika for recognition under an Innovative Research Award framework. The work applies an interdisciplinary research approach by connecting environmental exposure biomarkers with a quantitative indicator of phenotypic aging in a U.S. adult population. [1]

  • Research innovation: The study links environmental exposure assessment with laboratory-derived phenotypic aging measures.
  • Interdisciplinary relevance: The research spans environmental health, epidemiology, exposure science, and aging research.
  • Population relevance: NHANES provides a nationally collected U.S. population dataset for epidemiological investigation.
  • Research communication: The work is documented through a peer-reviewed journal publication with a persistent DOI.
  • Future research value: The findings can help motivate additional research into environmental determinants of biological aging.

Conclusion

Rubaiya Anika’s documented research contribution focuses on the relationship between urinary organophosphate metabolites and laboratory-derived phenotypic aging acceleration among U.S. adults using NHANES data from 1999–2018. The resulting publication demonstrates an interdisciplinary approach to environmental and population health research and provides a basis for further investigation of environmental influences on aging-related outcomes. [1]

References

  1. Anika, R., Untalan, M., Taioli, E., & Tuminello, S. (2026). Urinary Organophosphate Metabolites and Laboratory-Derived Phenotypic Aging Acceleration in U.S. Adults: Evidence from NHANES 1999–2018. International Journal of Environmental Research and Public Health, 23(9), 1126.
    https://doi.org/10.3390/ijerph23091126

WEN CHANG TSENG | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

WEN CHANG TSENG | Medicine and Health Sciences | Best Researcher Award

Mr WEN CHANG TSENG, Cathay General Hospital/Departmentof Radiology, Taiwan

Mr. Wen Chang Tseng is an accomplished medical radiologic technologist and deputy director with extensive expertise in diagnostic radiology and clinical trials. 📡🔬 With a career spanning over two decades (since 1999), he has contributed significantly to medical imaging and radiology, playing a key role in multinational clinical trials on ankylosing spondylitis and rheumatoid arthritis. 🏥 His work in advancing radiological technology has made a substantial impact in medical research, ensuring high standards in diagnostic procedures. 🎯 His dedication to improving patient care through innovative imaging techniques and clinical studies has earned him recognition as a leading expert in his field. 🌍 His contributions to Phase II and Phase III multinational studies highlight his commitment to advancing diagnostic radiology. 📈 His leadership in technology development, combined with his research experience, makes him a deserving recipient of the Best Researcher Award. 🏅👏

Publication Profile

Scopus

Education

Mr. Wen Chang Tseng holds a strong educational background in medical imaging and engineering. 🏛️ He earned his degree from the Department of Medical Imaging and Radiological Technology at Yuanpei University, where he gained in-depth knowledge of radiological sciences and medical imaging techniques. 🏥🔍 Expanding his technical expertise, he further pursued studies in the Department of Electrical Engineering at Chung Yuan Christian University, enhancing his understanding of technological applications in medical diagnostics. ⚡🖥️ His combined knowledge of radiology and electrical engineering allows him to develop and implement cutting-edge imaging solutions for enhanced patient diagnosis and treatment. 🏆 His education has provided a robust foundation for his career in medical radiology, clinical trials, and diagnostic imaging research. 🎯 His multidisciplinary academic training continues to support his innovative contributions to medical technology and radiology advancements. 📡🩻

Experience

With over two decades of experience in the field of diagnostic radiology, Mr. Wen Chang Tseng has been a cornerstone of medical imaging and radiologic technology. 🏆 Since 1999, he has been actively involved in the Diagnostic Radiology Department, applying his expertise in radiological imaging to enhance diagnostic accuracy. 🏥 His dedication and leadership have led him to serve as a Medical Radiologic Technologist and Deputy Director of Technology, where he has played a pivotal role in managing radiological procedures, research coordination, and advanced imaging technologies. 🔬🖥️ His work extends to supervising and conducting multinational clinical trials focusing on ankylosing spondylitis and rheumatoid arthritis. 🌎📊 His contributions have improved clinical imaging protocols and enhanced the reliability of diagnostic techniques. 🎯 His leadership in medical imaging research and development has made a lasting impact on the field of radiology. 🏅👏

Awards & Honors

Mr. Wen Chang Tseng’s contributions to medical imaging and radiological technology have been widely recognized through numerous accolades. 🏆 His expertise in diagnostic radiology and clinical trial research has earned him prestigious honors, including commendations for excellence in radiologic innovation and clinical research advancements. 🌟 As a leader in medical imaging research, he has been an integral part of groundbreaking Phase II and Phase III multinational studies on ankylosing spondylitis and rheumatoid arthritis. 📈 His pioneering role in clinical trials has led to significant improvements in diagnostic imaging standards, contributing to global advancements in radiology. 🌍 He has also been acknowledged by international research institutions for his commitment to technological advancements in radiologic sciences. 🔬 His dedication and innovation make him a distinguished figure in the field, making him a deserving recipient of the Best Researcher Award. 🏅🎯

Research Focus

Mr. Wen Chang Tseng specializes in diagnostic radiology, medical imaging technology, and clinical trial research. 📡 His work focuses on enhancing imaging techniques for ankylosing spondylitis and rheumatoid arthritis through Phase II and Phase III multinational clinical trials. 🏥 He has played a crucial role in advancing radiologic assessment methods, ensuring precise imaging for improved diagnosis and treatment planning. 🎯 His research integrates medical imaging with electrical engineering, allowing for the development of cutting-edge radiologic technologies. 🖥️⚡ His contributions to clinical trials have led to refined imaging protocols, benefiting global healthcare standards. 🌍 His multidisciplinary expertise in radiology and technology has driven innovation in diagnostic procedures, improving efficiency and accuracy in detecting musculoskeletal disorders. 📊 His research continues to shape the future of medical imaging, contributing to better patient care and medical advancements. 🏆

Publication Top Notes

Assessing the seasonality of occupancy number-associated CO2 level in a Taiwan hospital